Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions

Lade...
Vorschaubild
Dateien
Schildknecht_Characterization.pdf
Schildknecht_Characterization.pdfGröße: 7.4 MBDownloads: 1371
Datum
2012
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
ALTEX. 2012, 29(3), pp. 261-274. ISSN 1868-596X. Available under: doi: 10.14573/altex.2012.3.261
Zusammenfassung

Astrocytes are activated in most chronic neurodegenerative diseases associated with inflammatory events such as Parkinson’s disease or Alzheimer’s disease, but also in stroke. Due to an aging population worldwide, research efforts in these areas are likely to expand in the future. This will entail an increaseddemand for appropriate experimental models. We introduce here the new immortalized mouse astrocyte cell line IMA 2.1 as an alternative to currently used primary astrocyte cultures. IMA 2.1 were directly compared with primary mouse astrocytes with respect to their response to proinflammatory stimuli, expression of typical astrocyte markers, and to the cell line’s capacity to metabolize the parkinsonian toxin MPTP to its toxic metabolite MPP+. Under inflammatory conditions, mimicked with the addition of a cytokine mix, IMA 2.1 responded similarly to primary astrocytes with mRNA upregulation, expression of iNOS and COX-2, and the release of various inflammatory mediators. Analysis of astrocytic markers indicated that IMA 2.1 represent a relatively early, GFAP-negative stage of astrocyte development. Moreover, conversion of MPTP by monoamine oxidase-B proceeded in IMA at least as quickly as in primary cells. For all endpoints investigated, the cell line IMA 2.1, derived from a single clone, delivered reproducible results over a period of several years and allowed upscaling of experiments due to its easy handling compared with primary cells.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
astrocytes, LUHMES, inflammation, Parkinson’s disease, MPTP
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690SCHILDKNECHT, Stefan, Susanne KIRNER, Anja HENN, Karlo GASPARIC, Regina PAPE, Liudmila EFREMOVA, Olaf MAIER, Roman FISCHER, Marcel LEIST, 2012. Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions. In: ALTEX. 2012, 29(3), pp. 261-274. ISSN 1868-596X. Available under: doi: 10.14573/altex.2012.3.261
BibTex
@article{Schildknecht2012Chara-20157,
  year={2012},
  doi={10.14573/altex.2012.3.261},
  title={Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions},
  number={3},
  volume={29},
  issn={1868-596X},
  journal={ALTEX},
  pages={261--274},
  author={Schildknecht, Stefan and Kirner, Susanne and Henn, Anja and Gasparic, Karlo and Pape, Regina and Efremova, Liudmila and Maier, Olaf and Fischer, Roman and Leist, Marcel}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/20157">
    <dc:language>eng</dc:language>
    <dcterms:title>Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions</dcterms:title>
    <dc:creator>Kirner, Susanne</dc:creator>
    <dc:contributor>Pape, Regina</dc:contributor>
    <dcterms:abstract xml:lang="eng">Astrocytes are activated in most chronic neurodegenerative diseases associated with inflammatory events such as Parkinson’s disease or Alzheimer’s disease, but also in stroke. Due to an aging population worldwide, research efforts in these areas are likely to expand in the future. This will entail an increaseddemand for appropriate experimental models. We introduce here the new immortalized mouse astrocyte cell line IMA 2.1 as an alternative to currently used primary astrocyte cultures. IMA 2.1 were directly compared with primary mouse astrocytes with respect to their response to proinflammatory stimuli, expression of typical astrocyte markers, and to the cell line’s capacity to metabolize the parkinsonian toxin MPTP to its toxic metabolite MPP+. Under inflammatory conditions, mimicked with the addition of a cytokine mix, IMA 2.1 responded similarly to primary astrocytes with mRNA upregulation, expression of iNOS and COX-2, and the release of various inflammatory mediators. Analysis of astrocytic markers indicated that IMA 2.1 represent a relatively early, GFAP-negative stage of astrocyte development. Moreover, conversion of MPTP by monoamine oxidase-B proceeded in IMA at least as quickly as in primary cells. For all endpoints investigated, the cell line IMA 2.1, derived from a single clone, delivered reproducible results over a period of several years and allowed upscaling of experiments due to its easy handling compared with primary cells.</dcterms:abstract>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:contributor>Henn, Anja</dc:contributor>
    <dcterms:bibliographicCitation>First publ. in: Alternatives to animal experimentations : ALTEX ; 29 (2012), 3. - pp. 261-274</dcterms:bibliographicCitation>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>2012</dcterms:issued>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Henn, Anja</dc:creator>
    <dc:contributor>Efremova, Liudmila</dc:contributor>
    <dc:creator>Pape, Regina</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <dc:contributor>Gasparic, Karlo</dc:contributor>
    <dc:creator>Gasparic, Karlo</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/20157/1/Schildknecht_Characterization.pdf"/>
    <dc:creator>Maier, Olaf</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/20157/1/Schildknecht_Characterization.pdf"/>
    <dc:contributor>Fischer, Roman</dc:contributor>
    <dc:contributor>Schildknecht, Stefan</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Kirner, Susanne</dc:contributor>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-08-20T08:31:43Z</dc:date>
    <dc:creator>Schildknecht, Stefan</dc:creator>
    <dc:creator>Efremova, Liudmila</dc:creator>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/20157"/>
    <dc:contributor>Maier, Olaf</dc:contributor>
    <dc:creator>Fischer, Roman</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-08-20T08:31:43Z</dcterms:available>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen